Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Bausch Health Companies Inc (BHC)

$23.15 0.04 (0.17%)

16:49 EDT BHC Stock Quote Delayed 15 Minutes

Volume:

Previous Close $23.19

Market Cap -

PE Ratio -8.77

EPS -2.64

Volume (Avg. Vol.) 2.45M

Day's Range 22.95 - 23.36

52-Week Range 17.20 - 28.45

Dividend & Yield N/A (N/A)

BHC Stock Predictions, Articles, and Bausch Health Companies Inc News

From InvestorPlace
From the Web

10 Healthcare Stocks to Buy Despite the Headlines

By James Brumley, InvestorPlace Feature Writer Sep 10, 2019

Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.

Stock Market Today: How Many Times Will the Fed Cut Rates?

By Bret Kenwell, InvestorPlace Contributor Aug 6, 2019

After six straight sessions of losses, it was a welcomed sight to see stocks rally on Tuesday. Here's what happened on the stock market today.

10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019

By Vince Martin, InvestorPlace Contributor Jun 13, 2019

Wall Street analysts see significant upside in these 10 stocks to buy. And all ten have other reasons for optimism as well.

9 U.S. Stocks That Are Coming to Life Again

By James Brumley, InvestorPlace Feature Writer Feb 12, 2019

All-American U.S. stocks like Foot Locker, Copart and Snapchat are on the mend for all the right reasons. here are the charts to watch.

All Signals Are Positive for Buying Abbott Laboratories

By Chris Lau, InvestorPlace Contributor Jan 22, 2019

Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.

Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow

By Chris Lau, InvestorPlace Contributor Nov 8, 2018

Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.

Compare Brokers

7 Rising Healthcare Stocks to Consider

By Chris Lau, InvestorPlace Contributor Oct 29, 2018

Healthcare stocks recovered throughout 2018 but the recent correction in some big names is creating an entry point.

16 Stocks to Buy Before They Turn It Around

By Vince Martin, InvestorPlace Contributor Oct 11, 2018

GE stock is just one of the many turnaround stocks in the market. These 16 equities all could be stocks to buy - if execution improves.

5 Hot Stocks Today (That Could Crash Tomorrow)

By Bret Kenwell, InvestorPlace Contributor Jul 19, 2018

There are always hot stocks in the market but that doesn't mean investors should always buy -- they could be bull traps in the making.

Top Buys by Top Brass: CEO Papa's $699.3K Bet on BHC

From Market News Video Sep 19, 2019

A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..

Land This Deal Even Lower Than CEO Papa Did

From Market News Video Sep 19, 2019

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 13, Bausch Health Companies Inc's CEO, Joseph C..

Bausch Health down 1% on UnitedHealthcare exclusion of Siliq

From Seeking Alpha Sep 17, 2019

Bausch Health Companies (BHC -0.7%) is under modest pressure in apparent response to UnitedHealthcare's decision to drop coverage of plaque psoriasis med Siliq (brodalumab) effective January 1, 2020.

January 2022 Options Now Available For Bausch Health Companies (BHC)

From Market News Video Sep 16, 2019

Investors in Bausch Health Companies Inc (BHC) saw new options become available today, for the January 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 858 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Ardelyx Gets FDA Approval for Ibsrela As IBS-C Treatment

From Zacks Investment Research Sep 13, 2019

Ardelyx (ARDX) gets first-ever FDA approval for its pipeline candidate, tenapanor, as a treatment for irritable bowel syndrome with constipation in adults. It will be available under the tradename Ibsrela.

Bullish Two Hundred Day Moving Average Cross - BHC

From Market News Video Sep 12, 2019

In trading on Thursday, shares of Bausch Health Companies Inc (BHC) crossed above their 200 day moving average of $23.34, changing hands as high as $23.67 per share. Bausch Health Companies Inc shares are currently trading up about 1.6% on the day..

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!